Justin K Lee1, Melissa Assel2, Alan E Thong3, Daniel D Sjoberg2, John P Mulhall3, Jaspreet Sandhu3, Andrew J Vickers2, Behfar Ehdaie3. 1. Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: leej6@mskcc.org. 2. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 3. Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Abstract
BACKGROUND: It is generally assumed that if a man does not regain urinary continence or erectile function within 12 mo of radical prostatectomy (RP), then the chance of subsequent recovery is low. OBJECTIVE: To determine the probability of achieving good urinary function (UF) or erectile function (EF) up to 48 mo postoperatively in men who reported poor UF or EF at 12 mo after RP. DESIGN, SETTING, AND PARTICIPANTS: We identified 3187 patients who underwent RP from 2007 through 2013 at a tertiary institution and had extended multidisciplinary follow-up with patient-reported UF and EF scores at ≥12 mo. INTERVENTION: Open or minimally invasive RP. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Primary outcome was good UF as defined by a urinary score ≥17 (range: 0-21) or good EF as defined by a modified International Index of Erectile Function-6 score ≥22 (range: 1-30). The probability of functional recovery beyond 12 mo was determined by Kaplan-Meier analyses. RESULTS AND LIMITATIONS: Among patients incontinent at 12 mo, the probability of achieving good UF at 24, 36, and 48 mo was 30%, 49%, and 59%. In patients experiencing erectile dysfunction at 12 mo, the probability of recovering EF at 24, 36, and 48 mo was 22%, 32%, and 40%. On multivariable analyses, 12-mo functional score and age were associated with recovery, but only score was consistently significant. CONCLUSIONS: Men with incontinence or erectile dysfunction at 12 mo have higher than anticipated rates of subsequent functional improvement. Probability of recovery is strongly influenced by score at 12 mo. Further research should address the impact of ongoing multidisciplinary follow-up care on our observed rates of recovery. PATIENT SUMMARY: Many prostate cancer patients continue to recover urinary and erectile function after 12 mo. The level of functional recovery by 12 mo is associated with long-term recovery and should be discussed by the physician and patient when deciding on rehabilitative interventions.
BACKGROUND: It is generally assumed that if a man does not regain urinary continence or erectile function within 12 mo of radical prostatectomy (RP), then the chance of subsequent recovery is low. OBJECTIVE: To determine the probability of achieving good urinary function (UF) or erectile function (EF) up to 48 mo postoperatively in men who reported poor UF or EF at 12 mo after RP. DESIGN, SETTING, AND PARTICIPANTS: We identified 3187 patients who underwent RP from 2007 through 2013 at a tertiary institution and had extended multidisciplinary follow-up with patient-reported UF and EF scores at ≥12 mo. INTERVENTION: Open or minimally invasive RP. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Primary outcome was good UF as defined by a urinary score ≥17 (range: 0-21) or good EF as defined by a modified International Index of Erectile Function-6 score ≥22 (range: 1-30). The probability of functional recovery beyond 12 mo was determined by Kaplan-Meier analyses. RESULTS AND LIMITATIONS: Among patients incontinent at 12 mo, the probability of achieving good UF at 24, 36, and 48 mo was 30%, 49%, and 59%. In patients experiencing erectile dysfunction at 12 mo, the probability of recovering EF at 24, 36, and 48 mo was 22%, 32%, and 40%. On multivariable analyses, 12-mo functional score and age were associated with recovery, but only score was consistently significant. CONCLUSIONS:Men with incontinence or erectile dysfunction at 12 mo have higher than anticipated rates of subsequent functional improvement. Probability of recovery is strongly influenced by score at 12 mo. Further research should address the impact of ongoing multidisciplinary follow-up care on our observed rates of recovery. PATIENT SUMMARY: Many prostate cancerpatients continue to recover urinary and erectile function after 12 mo. The level of functional recovery by 12 mo is associated with long-term recovery and should be discussed by the physician and patient when deciding on rehabilitative interventions.
Authors: Jeffery W Saranchuk; Michael W Kattan; Elena Elkin; A Karim Touijer; Peter T Scardino; James A Eastham Journal: J Clin Oncol Date: 2005-06-20 Impact factor: 44.544
Authors: Alberto Briganti; Andrea Gallina; Nazareno Suardi; Umberto Capitanio; Manuela Tutolo; Marco Bianchi; Andrea Salonia; Renzo Colombo; Valerio Di Girolamo; Juan Ignazio Martinez-Salamanca; Giorgio Guazzoni; Patrizio Rigatti; Francesco Montorsi Journal: J Sex Med Date: 2011-01-26 Impact factor: 3.802
Authors: David F Penson; Dale McLerran; Ziding Feng; Lin Li; Peter C Albertsen; Frank D Gilliland; Ann Hamilton; Richard M Hoffman; Robert A Stephenson; Arnold L Potosky; Janet L Stanford Journal: J Urol Date: 2005-05 Impact factor: 7.450
Authors: Shilajit D Kundu; Kimberly A Roehl; Scott E Eggener; Jo Ann V Antenor; Misop Han; William J Catalona Journal: J Urol Date: 2004-12 Impact factor: 7.450
Authors: Martin G Sanda; Rodney L Dunn; Jeff Michalski; Howard M Sandler; Laurel Northouse; Larry Hembroff; Xihong Lin; Thomas K Greenfield; Mark S Litwin; Christopher S Saigal; Arul Mahadevan; Eric Klein; Adam Kibel; Louis L Pisters; Deborah Kuban; Irving Kaplan; David Wood; Jay Ciezki; Nikhil Shah; John T Wei Journal: N Engl J Med Date: 2008-03-20 Impact factor: 91.245
Authors: Sean F Mungovan; Jaspreet S Sandhu; Oguz Akin; Neil A Smart; Petra L Graham; Manish I Patel Journal: Eur Urol Date: 2016-07-06 Impact factor: 20.096
Authors: Paolo Capogrosso; Emily A Vertosick; Nicole E Benfante; James A Eastham; Peter J Scardino; Andrew J Vickers; John P Mulhall Journal: Eur Urol Date: 2018-09-17 Impact factor: 20.096
Authors: Vincenzo Pagliarulo; Stefano Alba; Maria Filomena Gallone; Marcello Zingarelli; Alfonso Lorusso; Paolo Minafra; Giuseppe Maria Ludovico; Savino Di Stasi; Pasquale Ditonno Journal: World J Urol Date: 2020-08-01 Impact factor: 4.226
Authors: F Abdollah; D Dalela; A Sood; J Sammon; R Cho; L Nocera; M Diaz; W Jeong; J O Peabody; N Fossati; G Gandaglia; A Briganti; F Montorsi; M Menon Journal: Prostate Cancer Prostatic Dis Date: 2017-05-02 Impact factor: 5.554
Authors: Kristine A Donovan; Brian D Gonzalez; Ashley M Nelson; Mayer N Fishman; Babu Zachariah; Paul B Jacobsen Journal: Psychooncology Date: 2017-06-27 Impact factor: 3.894
Authors: Justin K Lee; Daniel D Sjoberg; Mariam Imnadze Miller; Andrew J Vickers; John P Mulhall; Behfar Ehdaie Journal: Eur Urol Date: 2017-08-26 Impact factor: 20.096